The delivery of genome editing proteins to treat genetic diseases.
 00.00
 foreign  [Music]  every year about 10 million babies are  born with genetic disorders caused by  misspellings in their DNA the strains of  billions of A's C's G's and T's that  make up our genomes  just about any type of DNA misspelling  can cause a genetic disease swapping  this C with a t results in the rapid  aging disease progeria  replacing this a with a t causes painful  and deadly sickle cell disease  the deletion of these three DNA letters  is the most common cause of cystic 
 01.01
 fibrosis  and the insertion of extra DNA letters  causes tay-sex disease and Huntington's  disease  these misspellings in our DNA  collectively cause thousands of  disorders that affect hundreds of  millions of people and their families  driven largely by this problem  scientists have recently developed Gene  editing technologies that can change  these DNA misspellings to treat or maybe  even cure genetic diseases  one of these tools is this blue protein  called crispr cas9  which is programmed by a small piece of  RNA shown in green called the guide RNA  once the protein finds a Target DNA  sequence that matches the sequence in  the guide RNA it cuts that DNA breaking  the double helix into two pieces  cutting DNA is a very effective way to  disrupt a gene and bacteria evolved 
 02.00
 crispr as a defense system to mess up  the genes of infecting viruses  disrupting genes by cutting them with  crispr cas9 can also be very useful for  our own applications  this approach has already been used in  several clinical trials for example to  disrupt a gene that makes too much of a  protein that causes a deadly disease  called amyloidosis  so the era of human gene editing isn't  just coming it's already here  foreign  ly most genetic diseases can't be  treated by disrupting a gene  instead for most genetic disorders we  need to precisely correct the misspelled  gene into a healthy DNA sequence  in order to best benefit patients  even just six years ago the concept of  fixing a specific misspelling in the 
 03.00
 vast Genome of a live animal  seems like fanciful science fiction  yet today we can do exactly that  because our laboratory building on the  work of many other scientists recently  developed base editors and Prime editors  molecular machines that precisely  correct the misspellings that cause  genetic diseases by rearranging the  atoms in DNA  this adventure began in 2013 when I was  brainstorming projects by email with  Alexis comor a new postdoc in the lab  I pitched an idea  if you could directly convert one DNA  letter into another at a specified  position in the human genome efficiently  and without uncontrolled byproducts I  think you could transform genome  engineering and possibly human  Therapeutics  it was an exciting idea in theory but 
 04.00
 pulling it off would require going  beyond the DNA cutting scissors of  crispr cas9  we needed a machine that could search  for and bind a DNA sequence of our  choosing like cas9  but instead of cutting the target Gene  the machine would need to directly  correct a single letter misspelling  but how can we convert one DNA letter or  base into a different one  fortunately nature provides enzymes like  this one that can convert a c into a  base that looks like T through a known  chemical reaction  however they do so indiscriminately  to make this conversion occur at a  Target C of our choosing  Alexis attached one of these enzymes to  a disabled crispr cast 9 protein that  can still find the target sequence but  can no longer cut DNA  we were excited to see that in a test  tube the resulting engineered protein 
 05.00
 successfully converted a c of our  choosing into a t  but while this initial base editor  worked well in a test tube when we tried  it in living cells the converted base  was quickly removed by the cell undoing  our edit  to solve this problem we use this purple  protein taken from a different corner of  nature that protects the converted base  by attaching this small protein to the  rest of our machine we developed a  prototype base editor that for the first  time could convert C to T  or G to a at targeted sequences in the  genomes of living cells  but it only worked some of the time  because changing a c to a t creates a  disagreement within the DNA double helix  that confuses the cell  since C only pairs with G and T only  pairs with a  simply converting a c to a t results in 
 06.01
 this TG mismatch  if the cell resolves this disagreement  by replacing the T with a c then we end  up with our original sequence and once  again we've lost our edit  one morning Alexis came to me with a  solution to this problem she realized  that we could trick the cell into  resolving the mismatch in favor of our  edit  by making a small change in the machine  so it Nix the unedited DNA strand  containing the G  this Nick causes the cell to replace the  G on the unedited strand with an a as it  remakes The nift Strand  thereby completing the permanent  conversion of a CG base pair into a  stable ta-base pair  next we begin working on a second class  of Base editor one that could convert a  into G or t into C  this time however there was no enzyme we 
 07.02
 could borrow from nature that was known  to perform the necessary chemical  reaction  so Nicole goodelli another member of the  lab bravely agreed to try to evolve our  own enzyme to perform the needed  chemistry  despite taking on one of the most  ambitious projects in the lab at the  time  Nicole succeeded in evolving this red  protein  and her efforts resulted in this second  class of Base editor that converts a to  G and T to C at targeted basis of our  choosing  these two types of Base editors  developed by Alexis and Nicole in  principle can fix the most common kinds  of disease-causing misspellings in our  DNA representing about 30 percent of the  total  and in the six years since we first  reported base editing thousands of  Laboratories around the world have used  base editors to make precise 
 08.00
 single-letter DNA changes in organisms  ranging from bacteria to crops to people  base editors have recently been used in  animals to correct single letter  misspellings that cause devastating  genetic diseases  for example base editors now provide a  way to fix that c to T misspelling that  causes progeria  mice with this misspelled Gene suffer  rapid aging and early death like human  Progeria patients  here's an untreated Progeria Mouse at  seven months old  you can see that the misspelling causes  a thinned and whitened coat pronounced  curvature of the spine and a very low  activity level by this age  these Progeria mice pass away around  this time  far earlier than the two-year lifespan  of a normal Mouse  now I'm about to show you three Progeria  mice that each received a single  injection of Nicole's base editor 
 09.02
 programmed to correct the team  misspelling that causes Progeria back  into the normal sea  even though these mice are 11 months old  far older than any untreated Progeria  mice can live they show few apparent  symptoms of the disease  in fact Progeria mice given a one-time  injection of this base editor live about  two and a half times as long as  untreated mice reaching what would be  considered the start of old age in  normal mice  we're currently working with many other  scientists and doctors to advance this  treatment towards a clinical trial that  might offer Progeria children for the  first time a way to correct the root  cause of their disease  many other genetic diseases in animals  have also been treated with a one-time  dose of a base editor  for example by base editing bone marrow  to fix the misspelling that causes  sickle cell disease 
 10.01
 we restored normal blood parameters and  rescued the disease in mice  base editors have also been used in  animals to treat other diseases  including high cholesterol muscular  dystrophy ALS fennel ketoneuria  tyrosinemia Neiman pick disease and  genetic blindnesses  so base editors are powerful molecular  machines that can correct four of the  most common types of misspellings in our  DNA  but what about the remaining 70 percent  of known disease-associated misspellings  which include the eight other types of  single letter swaps as well as missing  letters and extra letters  we originally thought that it would take  scientists many years to develop all the  molecular machines needed to address the  rest of this pie chart  but in 2018 Andrew anzolone then a new  postdoc in the lab proposed a bold idea  that had the potential to correct almost 
 11.01
 any type of DNA misspelling in living  cells  he envisioned a molecular machine that  could directly rewrite DNA misspellings  with a strain of corrected letters  in a manner similar to a search and  replace function  so if crispr cast 9 is like scissors and  base editors are like pencils Andrew was  proposing to develop a DNA word  processor  Andrew imagined a new machine that uses  a guide RNA not only to specify where in  the genome the edit should be made but  also to encode what the corrected  sequence should be  in a special extension added to the end  of the guide RNA  the machine would then copy this  corrected sequence shown in yellow  into the target site in the genome  once again to move this idea from Theory  to reality seemed like an impossibly  long road 
 12.01
 in fact we broke down this ambitious  project into four challenges that seemed  so difficult that we skeptically named  them the four Small Miracles  first we had to test whether it was  possible to copy the yellow sequence in  the guide RNA extension into a Target  DNA site of our choosing  Andrew attached a special protein shown  in red that copies RNA sequences into  new stretches of DNA  to a disabled crispr protein shown in  blue  that once again can't cut the DNA double  helix but NYX one DNA strand at the  Target sequence  in a test tube Andrew programmed this  engineered protein with a special guide  RNA that contains the extension with the  corrected sequence shown in yellow  as well as a Runway shown here that  precisely aligns the target DNA strand  in white onto the guide RNA extension 
 13.04
 since the target DNA primes the copying  process  we named the system Prime editing  and remarkably in a test tube all the  parts of the system worked together to  copy the corrected sequence in yellow  from the extension in the guide RNA  directly onto the end of the target DNA  strand  the first small miracle was in hand  second what happens to the newly copied  DNA inside a living cell  the prime editor machine we engineered  makes a DNA flap containing the  corrected yellow sequence but there's no  guarantee that this precious flap would  end up replacing the original misspelled  DNA letters  we drew up this optimistic scheme  showing how the flap might end up  replacing the original DNA sequence in  cells but we really didn't know if cells  would cooperate 
 14.00
 when Andrew performed the first Prime  editing experiments in yeast which are  easier to work with than human cells he  was thrilled to discover that the newly  copied flap containing the corrected DNA  sequence  does often replace the original DNA  in fact the yellow East colonies shown  in this photo were the very first Prime  edited living cells  we had our second small miracle  next Andrew tried Prime editing human  cells  we held our breath and observed no  editing whatsoever  at this point many scientists would be  grateful to have made it this far and  would move on to a much safer project  but Andrew persisted and systematically  worked through a long list of potential  reasons why Prime editing initially  failed in human cells  ultimately he discovered that giving the 
 15.00
 red protein a Goldilocks length Runway  that was not too short and not too long  was critical  and resulted in a breakthrough  the very first Prime editing in human  cells  as excited as we were to observe any  Prime editing in human cells the initial  efficiency was terrible  for every 100 cells we treated one cell  might end up with the desired edit  to be useful Prime editing would need to  be much more efficient  Andrew tested dozens of variants of his  new editing machine and found a special  combination of these five changes in the  red protein supported much better  editing now often around 10 percent  efficiency  we then applied Alexis's trick used to  make base editors more efficient and  found that programming the prime Editor 
 16.01
 to Nick The non-edited Strand further  improved editing which could now exceed  even 50 percent in human cells  efficiency is considered useful and  potentially therapeutic for many  diseases  the lab buzzed with excitement after  Andrew completed his set of Small  Miracles resulting in this Prime editor  machine  as our lab members filed into my office  for our weekly meeting shortly after  Andrew observed the first efficient  Prime editing in human cells one grad  student turned to me as he walked by and  said  you are going to crap  and while that didn't quite happen I was  pretty excited  because Prime editing enables true  search and replace genome editing in  living cells  since you control the new sequence that  gets copied into the target DNA site 
 17.00
 you can replace any stretch of up to  dozens of DNA letters  with virtually any other stretch  so you can swap any letters insert  missing bases or delete extra ones  like deleting these four extra letters  that cause Tay sex disease  this versatility means that Prime  editing can correct the types of  misspellings that collectively account  for the vast majority of the known  errors in our DNA that cause genetic  disorders  we published this paper sharing Prime  editing with the public in late 2019.  more than 200 research papers have since  been published by Laboratories around  the world using prime editing in a wide  variety of living systems including  mammals  and just as we saw with base editing  Prime editing has already been used in  animals to rescue genetic diseases  including phenylketonuria tyrosinemia 
 18.00
 and sickle cell disease  much additional work lies ahead to  translate base editing and Prime editing  which each offer complementary strengths  into new medicines  I co-founded beam Therapeutics and Prime  medicine to bring in base editing and  Prime editing to patients  while the data in animals are  encouraging the safety and efficacy of  these Technologies in human patients  must be validated through clinical  trials  delivering these molecular machines into  the relevant cells in the body can be  challenging although methods such as the  one used to deliver covid-19 vaccines  into billions of people already have  shown promise  and we must work to ensure that all Gene  editing Technologies are applied in an  inclusive manner that thoughtfully  balances potential benefits and risks  including risks from off-target editing 
 19.00
 these challenges notwithstanding four  base editing clinical trials are already  underway in four countries to treat  diseases ranging from cancer to sickle  cell disease to high cholesterol  in a key Milestone just five and a half  years after our first Bay Saturday in  publication beam Therapeutics received  clearance from FDA to proceed with the  first base editing clinical trial in the  U.S which uses Nicole's base Editor to  treat sickle cell disease the world's  most common deadly monogenic disorder  second base editing clinical trial was  cleared from Verve Therapeutics and beam  Therapeutics to lower the risk of  coronary heart disease the leading cause  of death in this country  and just a couple months ago the first  clinical outcome from a base editing  therapeutic was announced  Alyssa the 13 year old girl in the UK  pictured here  had T Cell leukemia and was given a poor  prognosis after both chemotherapy and a 
 20.00
 bone marrow transplant failed to treat  her cancer  following treatment with T cells base  edited in three different genes to cause  them to attack alysses cancer but not  hurt healthy cells Alyssa's T Cell  leukemia went into complete remission  now more than seven months after  treatment her cancer remains undetected  and Prime medicine is leveraging the  remarkable versatility of prime edidine  to advance more than a dozen therapeutic  Prime editing programs towards clinical  trials  the use of human creativity and  resourcefulness to improve our condition  and those of our children is a defining  trait of our species  mentoring the students and postdocs who  built Brick by Brick base editing and  Prime editing technologies that allow us  to precisely correct errors in our  genomes has been the honor of my  professional life 
 21.00
 they give me hope that the future of  this field is very bright  and that one day we may finally no  longer be beholden to the misspellings  in our DNA  thank you  [Music]  thank you 




 
  
  
  
  
  
  
  
  
  
 